07/10/2018
https://congress.gov...
"I appreciate the need for the kinds of proposals listed under the heading of Advancing Regulatory Science and Innovation."
"I think it is going to be very difficult to do any of these new innovations if we see a 21 percent cut."
"This really shows that we are being bipartisan today."
"I would like to close by commenting on the importance of the Drug Safety Enhancement Act."